Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. (Q51377088)
Jump to navigation
Jump to search
scientific article published on 20 April 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. |
scientific article published on 20 April 2012 |
Statements
Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. (English)
1 reference
Wendy E Boertien
1 reference
Esther Meijer
1 reference
Debbie Zittema
1 reference
Marjan A van Dijk
1 reference
Martijn H Breuning
1 reference
Joachim Struck
1 reference
Stephan J L Bakker
1 reference
Dorien J M Peters
1 reference
Paul E de Jong
1 reference
Ron T Gansevoort
1 reference
20 April 2012
1 reference
27
1 reference
11
1 reference
4131-4137
1 reference